Neural Networks and Rules-based Systems used to Find Rational and Scientific Correlations between being Here and Now with Afterlife Conditions
Neural Networks and Rules-based Systems used to Find Rational and
Article Fingerprint
ReserarchID
46T34
Mycobacterium is acid fast genus of bacteria that include many pathogenic and non pathogenic species. Tuberculosis (TB) is the leading cause of death in the world from a bacterial infectious disease. The emergence of antibiotic resistance strains has raised the need towards the development of new antibiotics or drug molecules which can kill or suppress the growth of pathogenic Mycobacterium species. The increasing emergence of drug-resistant tuberculosis along with the HIV pandemic (human) threatens disease control and highlights both the need to understand how our current drugs work and the need to develop new and more effective drugs. Novel efforts in developing drugs that target the intracellular metabolism of M. tuberculosis often focus on metabolic pathways that are specific to mycobacterium. Potential drug targets were also identified from pathways related to lipid metabolism, carbohydrate metabolism, amino acid metabolism, energy metabolism, vitamin and cofactor biosynthetic pathways and nucleotide metabolism. Approximately one-fourth of the Mycobacterium tuberculosis genome contains genes that encode proteins directly involved in its metabolism. This review provides a brief historical account of tuberculosis drugs, metabolic pathways, examines the problem of current chemotherapy, discusses the targets of current tuberculosis drugs with focuses on some metabolic pathways. The identification of drug target form that unique metabolism of mycobacterium is crutial to to develop new drug for persistent and latent infection of tuberculosis.
Feyera Gemeda Dima. 2018. \u201cReview on Mycobacterial Metabolic Pathways as Drug Targets\u201d. Global Journal of Medical Research - C: Microbiology & Pathology GJMR-C Volume 18 (GJMR Volume 18 Issue C1): .
Crossref Journal DOI 10.17406/gjmra
Print ISSN 0975-5888
e-ISSN 2249-4618
The methods for personal identification and authentication are no exception.
Total Score: 72
Country: Ethiopia
Subject: Global Journal of Medical Research - C: Microbiology & Pathology
Authors: Ebsa Bushura, Feyera Gemeda Dima (PhD/Dr. count: 0)
View Count (all-time): 144
Total Views (Real + Logic): 2881
Total Downloads (simulated): 1501
Publish Date: 2018 07, Mon
Monthly Totals (Real + Logic):
Neural Networks and Rules-based Systems used to Find Rational and
A Comparative Study of the Effeect of Promotion on Employee
The Problem Managing Bicycling Mobility in Latin American Cities: Ciclovias
Impact of Capillarity-Induced Rising Damp on the Energy Performance of
Mycobacterium is acid fast genus of bacteria that include many pathogenic and non pathogenic species. Tuberculosis (TB) is the leading cause of death in the world from a bacterial infectious disease. The emergence of antibiotic resistance strains has raised the need towards the development of new antibiotics or drug molecules which can kill or suppress the growth of pathogenic Mycobacterium species. The increasing emergence of drug-resistant tuberculosis along with the HIV pandemic (human) threatens disease control and highlights both the need to understand how our current drugs work and the need to develop new and more effective drugs. Novel efforts in developing drugs that target the intracellular metabolism of M. tuberculosis often focus on metabolic pathways that are specific to mycobacterium. Potential drug targets were also identified from pathways related to lipid metabolism, carbohydrate metabolism, amino acid metabolism, energy metabolism, vitamin and cofactor biosynthetic pathways and nucleotide metabolism. Approximately one-fourth of the Mycobacterium tuberculosis genome contains genes that encode proteins directly involved in its metabolism. This review provides a brief historical account of tuberculosis drugs, metabolic pathways, examines the problem of current chemotherapy, discusses the targets of current tuberculosis drugs with focuses on some metabolic pathways. The identification of drug target form that unique metabolism of mycobacterium is crutial to to develop new drug for persistent and latent infection of tuberculosis.
We are currently updating this article page for a better experience.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.